rxstat › Shortages › Oxytocin
Oxytocin shortage status
Shortage anticipated
Source: Health Canada shortage reports · Updated Jul 9, 2026
A shortage of Oxytocin is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Reports by product
AnticipatedOXYTOCIN INJECTION USP
10UNIT · SOLUTION · PFIZER CANADA ULC
DIN 00497398 · Demand increase for the drug.
ResolvedOXYTOCIN INJECTION, USP
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Jan 8, 2026 · Delay in shipping of the drug.
ResolvedOXYTOCIN INJECTION USP
10UNIT · SOLUTION · PFIZER CANADA ULC
DIN 00497398 · ended Jan 7, 2026 · Disruption of the manufacture of the drug.
ResolvedOXYTOCIN INJECTION, USP
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Jun 19, 2024 · Disruption of the manufacture of the drug.
ResolvedOXYTOCIN INJECTION USP
10UNIT · SOLUTION · PFIZER CANADA ULC
DIN 00497398 · ended May 29, 2024 · Disruption of the manufacture of the drug.
ResolvedOXYTOCIN INJECTION, USP
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Mar 1, 2023 · Other (Please describe in comments)
ResolvedOXYTOCIN INJECTION, USP
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Apr 1, 2023 · Other (Please describe in comments)
ResolvedOXYTOCIN INJECTION, USP
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Nov 1, 2022 · Disruption of the manufacture of the drug.
ResolvedOXYTOCIN INJECTION, USP
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Jan 1, 2022 · Disruption of the manufacture of the drug.
ResolvedOXYTOCIN INJECTION
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Nov 8, 2019 · Demand increase for the drug.
ResolvedOXYTOCIN INJECTION
10UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02139561 · ended Nov 8, 2019 · Demand increase for the drug.
ResolvedOXYTOCIN INJECTION USP
10UNIT · SOLUTION · PFIZER CANADA ULC
DIN 00497398 · ended Nov 22, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Oxytocin to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Oxytocin is classified under “POSTERIOR PITUITARY LOBE HORMONES” (ATC H01BB).
Recent changes
Common questions
When will Oxytocin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Oxytocin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All posterior pituitary lobe hormones shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.